Maintenance therapy with either Lenalidomide or Bortezomib equally improves PFS and OS in High Risk Myeloma initially treated with Autotransplant.

Details

Language :

English

ISSN :

21522650

Volume :

19

Database :

Complementary Index

Journal :

Clinical Lymphoma, Myeloma & Leukemia

Publication Type :

Academic Journal

Accession number :

139237622

Full Text :

https://doi.org/10.1016/j.clml.2019.09.064